Meiji Yasuda Asset Management CO Ltd. Novo Cure LTD Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.57 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
265Shares Held
76.5MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$297 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$290 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$194 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$106 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$74.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.57B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...